Who Owns Foghorn Therapeutics Stock?
NASDAQ: FHTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 83.16%
- Held by insiders
- 14.20%
- Institutional holders
- 151
- Institutions 83.2%
- Insiders 14.2%
- Public and other 2.6%
Who owns Foghorn Therapeutics stock?
Institutional investors own about 83.2% of Foghorn Therapeutics's shares, spread across 151 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 14.20% of FHTX.
The largest institutional holders are Flagship Pioneering LLC (21.14%), BVF Inc. (9.74%) and FMR, LLC (9.25%). Together, the top 10 institutions control 64.6% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their FHTX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FHTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Flagship Pioneering LLC | 12.67M | 21.14% | 0.0% |
| BVF Inc. | 5.84M | 9.74% | 0.0% |
| FMR, LLC | 5.55M | 9.25% | -2.8% |
| Deerfield Management Company, L.P | 4.39M | 7.33% | 0.0% |
| Blackrock Inc. | 3.07M | 5.11% | +16.7% |
| Raymond James Financial, Inc. | 2.48M | 4.14% | -0.4% |
| Vanguard Capital Management LLC | 1.59M | 2.65% | +6.1% |
| Euclidean Capital Llc | 1.57M | 2.62% | 0.0% |
| Geode Capital Management, LLC | 861.65K | 1.44% | -5.4% |
| Siren, L.L.C. | 720.72K | 1.20% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FHTX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.83M | 3.06% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.03M | 1.71% |
| iShares Trust-iShares Russell 2000 ETF | 901.09K | 1.50% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 503.27K | 0.84% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 428.31K | 0.71% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 400.35K | 0.67% |
| iShares Trust-iShares Russell 2000 Growth ETF | 345.57K | 0.58% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 258.51K | 0.43% |
| iShares Trust-iShares Biotechnology ETF | 245.00K | 0.41% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 214.08K | 0.36% |
Frequently asked questions
Who is the largest shareholder of Foghorn Therapeutics?
Flagship Pioneering LLC is the largest institutional shareholder of FHTX, owning 21.14% of shares outstanding (12.67M shares) as of its latest 13F filing.
What percentage of Foghorn Therapeutics is owned by institutions?
Institutions own about 83.2% of FHTX shares and 96.9% of the public float.
How much of Foghorn Therapeutics do insiders own?
Insiders, such as officers and directors, own about 14.20% of FHTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.